Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14,419 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Liposomal eribulin for advanced adenoid cystic carcinoma, gastric cancer, esophageal cancer, and small cell lung cancer.
Udagawa H, Takahashi S, Hirao M, Tahara M, Iwasa S, Sato Y, Hamakawa T, Shitara K, Horinouchi H, Chin K, Masuda N, Suzuki T, Okumura S, Takase T, Nagai R, Yonemori K. Udagawa H, et al. Among authors: sato y. Cancer Med. 2023 Jan;12(2):1269-1278. doi: 10.1002/cam4.4996. Epub 2022 Jul 21. Cancer Med. 2023. PMID: 35864593 Free PMC article.
Predictive factors of head and neck squamous cell carcinoma patient tolerance to high-dose cisplatin in concurrent chemoradiotherapy.
Nakano K, Sato Y, Toshiyasu T, Sato Y, Inagaki L, Tomomatsu J, Sasaki T, Shimbashi W, Fukushima H, Yonekawa H, Mitani H, Kawabata K, Takahashi S. Nakano K, et al. Among authors: sato y. Mol Clin Oncol. 2016 Feb;4(2):303-309. doi: 10.3892/mco.2015.687. Epub 2015 Nov 25. Mol Clin Oncol. 2016. PMID: 26893880 Free PMC article.
Integrative immunogenomic analysis of gastric cancer dictates novel immunological classification and the functional status of tumor-infiltrating cells.
Sato Y, Wada I, Odaira K, Hosoi A, Kobayashi Y, Nagaoka K, Karasaki T, Matsushita H, Yagi K, Yamashita H, Fujita M, Watanabe S, Kamatani T, Miya F, Mineno J, Nakagawa H, Tsunoda T, Takahashi S, Seto Y, Kakimi K. Sato Y, et al. Clin Transl Immunology. 2020 Oct 17;9(10):e1194. doi: 10.1002/cti2.1194. eCollection 2020. Clin Transl Immunology. 2020. PMID: 33101677 Free PMC article.
Tumor growth rate as a prognostic factor for metastatic or recurrent adenoid cystic carcinoma of the head and neck patients treated with carboplatin plus paclitaxel.
Fukuda N, Fujiwara Y, Wang X, Ohmoto A, Urasaki T, Hayashi N, Sato Y, Nakano K, Yunokawa M, Ono M, Tomomatsu J, Takahashi S. Fukuda N, et al. Among authors: sato y. Eur Arch Otorhinolaryngol. 2021 Aug;278(8):3037-3043. doi: 10.1007/s00405-020-06481-y. Epub 2020 Nov 21. Eur Arch Otorhinolaryngol. 2021. PMID: 33219858
Differences in the efficacy and safety of eribulin in patients with soft tissue sarcoma by histological subtype and treatment line.
Nakano K, Hayakawa K, Funauchi Y, Tanizawa T, Ae K, Matsumoto S, Tomomatsu J, Ono M, Taira S, Nishizawa M, Wang X, Ohmoto A, Sato Y, Fukuda N, Urasaki T, Takahashi S. Nakano K, et al. Among authors: sato y. Mol Clin Oncol. 2021 Jan;14(1):13. doi: 10.3892/mco.2020.2175. Epub 2020 Nov 25. Mol Clin Oncol. 2021. PMID: 33282288 Free PMC article.
Comparison of the efficacy and safety of the EXTREME regimen for treating recurrent or metastatic head and neck squamous cell carcinoma in older and younger adult patients.
Fukuda N, Yunokawa M, Fujiwara Y, Wang X, Ohmoto A, Hayashi N, Urasaki T, Sato Y, Nakano K, Ono M, Tomomatsu J, Mitani H, Takahashi S. Fukuda N, et al. Among authors: sato y. Cancer Rep (Hoboken). 2021 Apr;4(2):e1322. doi: 10.1002/cnr2.1322. Epub 2020 Dec 9. Cancer Rep (Hoboken). 2021. PMID: 33295110 Free PMC article.
14,419 results
You have reached the last available page of results. Please see the User Guide for more information.